Tag: biosimilars

Biocon is strategically pursuing in-licensing opportunities to bolster its biosimilars portfolio and drive significant margin expansion, leveraging a multi-product launch cycle and a shift towards consolidating its global commercial ...

New Delhi: Biocon Ltd on Tuesday announced the commercial launch of biosimilars Bosaya and Aukelso, indicated for different serious bone conditions, in the US.Bosaya (biosimilar to Prolia) and Aukelso ...

Dr Reddy’s Laboratories is looking to sharpen focus on biosimilars and innovation while continuing to fetch majority of revenues from generics and active pharmaceutical ingredients, said GV Prasad, co-chairman ...

Dr Reddy's Laboratories (DRL) has joined the race to acquire the biosimilar products portfolio of US-based Biogen in a transaction worth a potential $1 billion, according to two people ...

Biocon Biologics is on track to integrate a major part of the acquired biosimilars business of long-term partner Viatris in the current fiscal, the company's Executive Chairperson Kiran Mazumdar-Shaw ...

Expanding its footprint in the emerging markets, Biocon Biologics, an arm of biopharmaceutical company major Biocon, on Wednesday announced that it has completed the integration of the biosimilars business ...

Bengaluru: Biocon Biologics Ltd (BBL) announced that the company has completed the integration of the acquired biosimilars business in over 70 countries in Emerging Markets effective July 1, 2023, ...

New Delhi: India's Biocon Biologics closed the 12 months to end-March with revenue on a trajectory in direction of $1 billion, its CEO stated on Wednesday, helped by robust ...